Skip to main content

Table 3 Results of linear regression for the association between DII and biochemical variables among the patients with T2DM

From: The association between dietary inflammatory index with some cardio-metabolic risk indices among the patients with type 2 diabetes from Hoveyzeh cohort study: a cross-sectional study

Variable

DII tertiles

P trend

T1

T2

T3

 

β

SE

P1

β

SE

P1

FBS (mg/dl)

        

Crude

Ref

2.12

3.90

0.32

3.85

3.94

0.61

0.33

Model 1

Ref

1.26

3.99

0.46

2.90

3.95

0.75

0.48

Model 2

Ref

2.17

4.05

0.25

4.51

3.98

0.59

0.27

Model 3

Ref

3.28

4.04

0.08

7.06

3.94

0.41

0.29

TG (mg/dl)

        

Crude

Ref

9.02

7.53

0.23

18.48

7.43

0.014

0.02

Model 1

Ref

9.59

7.54

0.21

19.46

7.62

0.01

0.025

Model 2

Ref

11.60

7.59

0.13

20.28

7.73

0.008

0.005

Model 3

Ref

10.68

7.58

0.17

19.62

7.76

0.01

0.03

Cholesterol (mg/dl)

        

Crude

Ref

0.25

2.56

0.92

2.23

2.66

0.38

0.27

Model 1

Ref

1.04

2.33

0.52

1.63

2.59

0.68

0.59

Model 2

Ref

1.01

2.58

0.7

1.68

2.63

0.52

0.49

Model 3

Ref

0.78

2.48

0.77

1.79

2.69

0.49

0.48

LDL (mg/dl)

        

Crude

Ref

0.91

2.1

0.65

1.49

2.36

0.46

0.45

Model 1

Ref

1.34

2.02

0.51

2.30

2.64

0.26

0.24

Model 2

Ref

1.56

2.01

0.43

2.74

2.05

0.18

0.19

Model 3

Ref

1.42

2.02

0.48

2.48

2.07

0.23

0.24

HDL (mg/dl)

        

Crude

Ref

0.26

0.63

0.68

0.39

0.63

0.54

0.55

Model 1

Ref

0.59

0.61

0.33

1.002

0.62

0.107

0.107

Model 2

Ref

0.501

0.62

0.42

0.97

0.64

0.124

0.13

Model 3

Ref

0.36

0.61

0.56

0.73

0.63

0.24

0.25

ALT

        

Crude

Ref

0.33

0.66

0.62

0.96

0.67

0.14

0.15

Model 1

Ref

0.21

0.66

0.75

0.89

0.67

0.18

0.21

Model 2

Ref

0.29

0.67

0.66

0.99

0.68

0.15

0.11

Model 3

Ref

0.41

0.67

0.53

1.26

0.68

0.04

0.02

AST

        

Crude

Ref

0.23

0.74

0.75

1.20

0.74

0.106

0.11

Model 1

Ref

0.07

0.72

0.92

1.45

0.73

0.04

0.02

Model 2

Ref

0.15

0.73

0.84

1,58

0.82

0.036

0.035

Model 3

Ref

0.07

0.72

0.92

1.69

0.84

0.03

0.033

BUN

        

Crude

Ref

0.31

0.3

0.32

0.73

1.12

0.15

0.11

Model 1

Ref

0.32

0.28

0.43

0.89

1.13

0.08

0.03

Model 2

Ref

0.11

0.29

0.34

0.92

1.13

0.039

0.012

Model 3

Ref

0.12

0.28

0.5

1.12

1.15

0.023

0.01

Cr

Crude

Ref

0. 17

0. 23

0.23

0.3

0. 21

0.13

0.12

Model 1

Ref

0. 25

0. 22

0.17

0.43

0.27

0.06

0.05

Model 2

Ref

0. 13

0. 20

0.31

0.44

0.33

0.03

0.02

Model 3

Ref

0.19

0.24

0.25

0.51

0.35

0.01

0.01

LAP

        

Crude

Ref

821.57

326.45

0.003

981.32

326.33

0.012

0.012

Model 1

Ref

705.62

325.99

0.002

965.33

329.66

0.03

0.033

Model 2

Ref

964.78

326.22

0.001

1107.60

332.26

0.001

0.004

TyG

        

Crude

Ref

0.08

0.038

0.022

0.1

0.04

0.038

0.008

Model 1

Ref

0.09

0.04

0.012

0.12

0.042

0.002

0.009

Model 2

Ref

0.09

0.038

0.014

0.122

0.038

0.002

0.002

Model 3

Ref

0.1

0.04

0.01

0.13

0.041

0.003

0.004

  1. Model 1, adjusted for gender, education level, smoking, alcohol and age, Model 2, Model 1 plus physical activity and calorie intake, Model 3, Model 1 and Model 2 plus waist circumference and BMI. ALT, alanine amino transferase; AST, aspartate amino transferase; BUN, blood urea nitrogen; Cr, creatinine; CHOL, cholesterol; FBS, Fasting blood sugar; HDL, high density lipoprotein; LAP, Lipid accumulation product; TG, triglyceride; TyG, triglyceride glucose index
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us